ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,385,000 | +13.4% | 179,500 | -29.2% | 0.00% | 0.0% |
| Q2 2019 | $2,984,000 | +62.8% | 253,550 | +88.9% | 0.00% | +100.0% |
| Q1 2019 | $1,833,000 | +1597.2% | 134,250 | +1178.6% | 0.00% | – |
| Q4 2018 | $108,000 | -78.4% | 10,500 | -65.0% | 0.00% | -100.0% |
| Q3 2018 | $500,000 | +216.5% | 30,000 | +200.0% | 0.00% | – |
| Q2 2018 | $158,000 | -66.7% | 10,000 | -31.0% | 0.00% | -100.0% |
| Q3 2016 | $475,000 | -4.8% | 14,500 | -27.5% | 0.00% | 0.0% |
| Q2 2016 | $499,000 | -16.1% | 20,000 | +11.1% | 0.00% | 0.0% |
| Q4 2015 | $595,000 | -43.8% | 18,000 | -10.0% | 0.00% | 0.0% |
| Q2 2015 | $1,059,000 | +62.2% | 20,000 | -10.9% | 0.00% | 0.0% |
| Q4 2014 | $653,000 | – | 22,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |